Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma-Reference-Cited by-同舟云学术

Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma

Published:2008-10-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bohlius Julia¹,Herbst Christine¹,Reiser Marcel²,Schwarzer Guido³,Engert Andreas¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group - Department of Internal Medicine 1; Kerpener Str. 62 Cologne Germany 50924

2. University Hospital of Cologne; Department of Internal Medicine 1; Kerpener Str. 62 Cologne Germany 50924

3. German Cochrane Center; Department of Medical Biometry and Statistics; University Medical Center Stefan-Meier-Str. 26 Freiburg Germany D-79104

Publisher

Wiley

Subject

Pharmacology (medical)

Reference143 articles.

1. Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease;Aglietta;Cancer,2000

2. Personal communication in addition to Aglietta 2000

3. Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy;Avilés;Leukemia and Lymphoma,1994

4. Personal communication in addition to Avilès 1994

5. Bastion Y Bosly A Gisselbrecht C Reyes F Tilly H Herbrecht R A randomized double-blind phase III study of Filgrastim (recombinant human G-CSF) vs placebo during intensive induction chemotherapy in 55 to 59 year old patients (pts) with poor prognosis aggressive Non-Hodgkin's Lymphoma Blood 1993

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of solid tumors;Cochrane Database of Systematic Reviews;2024-01-16

2. Impact of PEG-GCSF in Breast Cancer Patients Undergoing Chemotherapy During the COVID-19 Pandemic: Single Center Experience and Literature Review;In Vivo;2024

3. Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors;Cancer Medicine;2024-01

4. The Relative Dose Intensity Changes during Cycles of Standard Regimens in Patients with Diffuse Large B-Cell Lymphoma;Cancers;2023-09-07

5. Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP;Annals of Hematology;2023-08-21